Emergent BioSolutions EBS
NYSE EBS
$5.08 +0.26 (+5.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) (2010 - 2026)

Emergent BioSolutions (EBS) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 2.55 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 3.93 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 3.76 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 13.44 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 1.93 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 2.44 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 90.50 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 1.41 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 2.96 Bn
10 Emergent BioSolutions 261.35 Mn 120.45 Mn 137.20 Mn 178.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 178.00 Mn
Jun 30, 2026 178.00 Mn
Mar 31, 2026 199.40 Mn
Mar 31, 2026 199.40 Mn
Dec 31, 2025 205.40 Mn
Dec 31, 2025 205.40 Mn
Sep 30, 2025 209.80 Mn
Sep 30, 2025 209.80 Mn
Jun 30, 2025 216.10 Mn
Jun 30, 2025 216.10 Mn
Mar 31, 2025 221.00 Mn
Mar 31, 2025 221.00 Mn
Dec 31, 2024 270.60 Mn
Dec 31, 2024 270.60 Mn
Sep 30, 2024 278.10 Mn
Sep 30, 2024 278.10 Mn
Jun 30, 2024 306.20 Mn
Jun 30, 2024 306.20 Mn
Mar 31, 2024 379.40 Mn
Mar 31, 2024 379.40 Mn